Healthcare -
Biotechnology - NASDAQ - US
$ 11.7775
-1.36 %
$ 443 M
Market Cap
7.01
P/E
TRDA - CAPITAL EXPENDITURES
Capital Expenditures TRDA - Entrada Therapeutics, Inc.
-5.61 M
LAST VALUE
-10.71%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR